ArticleVaccines2024

Development of a Highly Efficient CRISPR/Cas9-Mediated Herpesvirus of Turkey-Based Vaccine against Novel Variant Infectious Bursal Disease Virus.

Jun-Feng Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.